Exhibit 32(b)


              CERTIFICATION OF CHIEF FINANCIAL OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO
            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the IGENE Biotechnology, Inc. (the "Company")
Quarterly Report on Form 10-QSB/A for the period ended March 31, 2004
as  filed  with the Securities and Exchange Commission  on  the  date
hereof  (the  "Report"),  I,  Edward J. Weisberger,  Chief  Financial
Officer  of the Company, certify pursuant to 18 U.S.C. Section  1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to the best of my knowledge:

          (1).  The  Report  fully complies with the requirements  of
          Section  13(a) or 15(d) of the Securities Exchange  Act  of
          1934, as amended; and

          (2).   The  information  contained  in  the  Report  fairly
          presents, in all material respects, the financial condition
          and results of operations of the Company.


Date: September 28, 2005           By:  /s/EDWARD J. WEISBERGER
                                       ______________________________
                                           EDWARD J. WEISBERGER
                                           Chief Financial Officer


A  signed original of this written statement required by Section  906
has  been provided to the Company and will be retained by the Company
and  furnished to the Securities and Exchange Commission or its staff
upon request.